0000899243-20-019904.txt : 20200721 0000899243-20-019904.hdr.sgml : 20200721 20200721195401 ACCESSION NUMBER: 0000899243-20-019904 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200721 FILED AS OF DATE: 20200721 DATE AS OF CHANGE: 20200721 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pons Jaume CENTRAL INDEX KEY: 0001816977 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39386 FILM NUMBER: 201039978 MAIL ADDRESS: STREET 1: C/O ALX ONCOLOGY HOLDINGS INC. STREET 2: 866 MALCOLM ROAD, SUITE 100 CITY: BURLINGAME STATE: CA ZIP: 94010 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALX ONCOLOGY HOLDINGS INC CENTRAL INDEX KEY: 0001810182 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 850642577 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 866 MALCOLM ROAD, SUITE 100 CITY: BURLINGAME STATE: CA ZIP: 94010 BUSINESS PHONE: 650-466-7125 MAIL ADDRESS: STREET 1: 866 MALCOLM ROAD, SUITE 100 CITY: BURLINGAME STATE: CA ZIP: 94010 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-07-21 0 0001810182 ALX ONCOLOGY HOLDINGS INC ALXO 0001816977 Pons Jaume C/O ALX ONCOLOGY HOLDINGS INC. 866 MALCOLM ROAD, SUITE 100 BURLINGAME CA 94010 1 1 0 0 President and CEO Common Stock 2020-07-21 4 C 0 27292 A 541346 D Series A Convertible Preferred Stock 2020-07-21 4 C 0 20225 D Common Stock 20225 0 D Series A Convertible Preferred Stock 2020-07-21 4 C 0 1803 D Common Stock 1803 0 D Series C Convertible Preferred Stock 2020-07-21 4 C 0 5264 D Common Stock 5264 0 D Each share of Series A Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date. Each share of Series B Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date. Each share of Series C Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date. Includes 4,982 shares of Common Stock issued as payment of accrued dividends upon conversion of the preferred stock on July 21, 2020. /s/ Peter Garcia, by power of attorney 2020-07-21